Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches

被引：0
作者：
Óscar Soto-Angona
Gerard Anmella
María José Valdés-Florido
Nieves De Uribe-Viloria
Andre F. Carvalho
Brenda W. J. H. Penninx
Michael Berk
机构：
[1] Vall d’Hebron University Hospital,Department of Psychiatry
[2] Barwon Health,Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine
[3] University of Barcelona,Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clinic
[4] IDIBAPS,UGC Salud Mental
[5] CIBERSAM,Department of Psychiatry
[6] Hospital Universitario Virgen Macarena,Department of Psychiatry
[7] Hospital Clínico Universitario de Valladolid,Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience
[8] University of Toronto,Orygen, The National Centre of Excellence in Youth Mental Health, the Department of Psychiatry, and the Florey Institute of Neuroscience and Mental Health
[9] Centre for Addiction and Mental Health (CAMH),undefined
[10] Amsterdam University Medical Center/Vrije Universiteit & GGZinGeest,undefined
[11] The University of Melbourne,undefined
来源：
BMC Medicine | / 18卷
关键词：
Non-alcoholic fatty liver disease; Metabolic syndrome; Mental disorders; Psychiatry; Non-alcoholic steatohepatitis; Non-communicable disorders; Lifestyle; Inflammation; Oxidative stress; Mitochondrial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 348 条
[81]  
Riecher-Rössler S(2015)Relation of physical activity to prevalence of nonalcoholic fatty liver disease independent of cardiometabolic risk Am J Cardiol 115 34-439
[82]  
Butler J(2012)Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study J Hepatol 57 1305-436
[83]  
Kulkarni S(2016)Perception of effort during activity in patients with chronic hepatitis C and nonalcoholic fatty liver disease PM R 8 28-5097
[84]  
Menghini-Müller E(2019)Impact of current diet at the risk of non-alcoholic fatty liver disease (NAFLD) Arq Gastroenterol 56 431-56
[85]  
Studerus S(2017)Nutritional psychiatry: the present state of the evidence Proc Nutr Soc 76 427-103
[86]  
Ittig JJ(2016)Psychological factors associated with NAFLD/NASH: a systematic review Eur Rev Med Pharmacol Sci 20 5081-1186
[87]  
Pan MB(2017)Exercise and mental health Maturitas. 106 48-712
[88]  
Fallon P(2020)NASH (nonalcoholic steatohepatitis), diabetes, and macrovascular disease: multiple chronic conditions and a potential treatment at the metabolic root Expert Opin Investig Drugs 0 1-30
[89]  
Carrier M(2018)Repositioning of diabetes treatments for depressive symptoms: a systematic review and meta-analysis of clinical trials Psychoneuroendocrinology. 94 91-548
[90]  
Debette-Gratien M(2010)Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis [1] N Engl J Med 363 1185-7
45678910111213